Enhancement of Quality of Work And Life: A Personalised Primary Preventive Work Intervention to Enhance Sustainable Work Participation in Persons With Neurodegenerative Movement Disorders

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Work participation is essential for quality of life, providing purpose, social interaction, financial security, and shaping social status. Work participation is increasingly compromised in people with slowly progressive chronic disorders (hereafter referred to as progressive disorders). This negatively impacts their quality of life. Early work-related support, focused on sustainable work-retention, has the potential to enhance work participation in people with progressive disorders. Therefore, this study investigates the (cost)effectiveness of the Preventive Participatory Workplace Intervention (PPWI), a personalized work intervention to enhance sustainable work participation. The investigators perform an 18-month randomized controlled trial (RCT). In addition, the investigators perform a process evaluation and an economic evaluation alongside the RCT. 124 Dutch working persons with three types of movement disorders will be included: Parkinson's Disease (PD), cerebellar ataxia (CA) and hereditary spastic paraparesis (HSP) and with slowly progressive neuromuscular and mitochondrial disorders.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• having a diagnosis Parkinson Disease, cerebellar ataxia, hereditairy spastic paraparesis, or a slowly progressive neuromuscular or mitochondrial disorder, confirmed by the treating physician (e.g. neurologist, rehabilitation physician)

• aged 18-65 years;

• being employed for at least 8 hours per week (at baseline). This also includes individuals who have reduced their working hours until reaching this threshold of 8 hours per week. Working time may be distributed across multiple working days;

• having the intention to continue to work during the study period of 18 months, to prevent inclusion of participants who plan to retire within the 18-month RCT period;

• being open to talk to the employer or manager about any changes or limitations in work performance (disclosing the diagnosis is not required, by law).

Locations
Other Locations
Netherlands
Radboudumc
RECRUITING
Nijmegen
Contact Information
Primary
Pauline van Barschot
pauline.vanbarschot@radboudumc.nl
+31615483989
Backup
Elbrich Postma, PhD
elbrich.postma@radboudumc.nl
Time Frame
Start Date: 2024-10-08
Estimated Completion Date: 2027-01-04
Participants
Target number of participants: 124
Treatments
Experimental: Preventive Participatory workplace intervention (PPWI)
Participants in the PPWI group will receive the PPWI and continue to receive usual care.
No_intervention: Usual care control group
The usual care control group comprises usual care. There are no restrictions on usual care.
Sponsors
Leads: Radboud University Medical Center
Collaborators: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), The Dutch Brain Foundation

This content was sourced from clinicaltrials.gov